SPAC14C4.10c Antibody

What is SPAC14C4.10c and why is it studied in research?

SPAC14C4.10c refers to a specific gene in Schizosaccharomyces pombe (fission yeast) that encodes a protein with the same designation. S. pombe serves as an important model organism in molecular and cellular biology due to its relatively simple genome and its genetic similarity to higher eukaryotes, including humans. SPAC14C4.10c antibody enables researchers to detect, quantify, and localize this protein in experimental systems.

The study of SPAC14C4.10c contributes to our understanding of fundamental cellular processes in eukaryotes. Researchers typically investigate this protein in contexts such as cell cycle regulation, stress response mechanisms, or cellular signaling pathways. The antibody provides a valuable tool for visualizing protein expression patterns and interactions that would otherwise be difficult to detect through genetic approaches alone .

What applications is the SPAC14C4.10c antibody validated for?

The SPAC14C4.10c antibody has been validated primarily for Western Blotting (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) applications. These techniques allow researchers to detect and quantify the target protein in various experimental conditions .

Western Blotting enables scientists to determine protein molecular weight, expression levels, and potential post-translational modifications. ELISA applications provide quantitative measurement of the target protein in solution. Both methods rely on the specific binding between the antibody and the SPAC14C4.10c protein, which can be visualized using appropriate detection systems.

How should SPAC14C4.10c antibody be stored and handled for optimal performance?

The SPAC14C4.10c antibody requires careful storage and handling to maintain its functionality. According to manufacturer specifications, the antibody should be stored at either -20°C or -80°C for long-term stability . When working with the antibody, researchers should consider the following protocol:

• Aliquot the antibody upon first thawing to minimize freeze-thaw cycles

• Store working dilutions at 4°C for short-term use (typically 1-2 weeks)

• Avoid repeated freeze-thaw cycles as they can contribute to antibody degradation

• Centrifuge the antibody vial briefly before opening to collect liquid at the bottom

• Use sterile technique when handling to prevent contamination

Adherence to these storage and handling procedures helps maintain antibody integrity and ensures consistent experimental results across multiple investigations.

What controls should be included when using SPAC14C4.10c antibody?

Proper experimental controls are essential for validating results obtained with SPAC14C4.10c antibody. The manufacturer provides both positive and negative controls that should be included in experimental design:

• Positive control: 200μg of antigens used for immunization serves as a reference for specific binding

• Negative control: 1ml pre-immune serum helps establish baseline and non-specific binding levels

Additional recommended controls include:

• Loading control: Antibody against a housekeeping protein (e.g., actin, tubulin) to normalize protein levels

• Knockout/knockdown control: Samples where SPAC14C4.10c expression has been eliminated or reduced

• Species-specific secondary antibody control: To verify secondary antibody specificity

Including these controls helps distinguish specific signal from background noise and validates the antibody's performance in each experimental context.

How can epitope mapping be performed for SPAC14C4.10c antibody to enhance experimental design?

Epitope mapping for SPAC14C4.10c antibody provides crucial information about the specific protein region being recognized, which can inform experimental design and interpretation. Several methodological approaches can be employed:

• Peptide array analysis: Synthesize overlapping peptides spanning the SPAC14C4.10c sequence and probe with the antibody to identify binding regions.

• Computational prediction with experimental validation: Utilize structure-based computational tools to predict antibody-antigen interactions and validate through mutagenesis .

• Mass spectrometry epitope mapping: Digest antibody-antigen complexes and analyze through mass spectrometry to identify protected regions.

• Deletion mutation analysis: Create truncated versions of SPAC14C4.10c and test reactivity with the antibody.

Understanding the epitope recognized by the antibody can help researchers predict potential cross-reactivity, accessibility in different experimental conditions, and sensitivity to protein modifications or conformational changes. This knowledge significantly enhances experimental design by allowing researchers to anticipate limitations in specific applications.

What strategies can overcome specificity challenges when using SPAC14C4.10c antibody in complex S. pombe protein mixtures?

When working with complex S. pombe protein mixtures, researchers may encounter specificity challenges that require methodological solutions:

• Pre-absorption technique: Incubate the antibody with recombinant proteins that share homology with SPAC14C4.10c to eliminate cross-reactive antibodies.

• Two-dimensional Western blotting: Separate proteins based on both molecular weight and isoelectric point to enhance resolution and reduce background.

• Native vs. denaturing conditions: Compare antibody performance under different conditions to optimize specificity for the intended application.

• Sequential immunoprecipitation: Perform multiple rounds of immunoprecipitation to increase specificity.

• Titration experiments: Determine optimal antibody concentration to maximize specific signal while minimizing background.

These advanced approaches help ensure that signals detected in experiments genuinely represent SPAC14C4.10c rather than cross-reactive proteins with similar epitopes or properties.

How does SPAC14C4.10c antibody perform in immunoprecipitation for protein-protein interaction studies?

While the SPAC14C4.10c antibody is primarily validated for Western blotting and ELISA, researchers interested in protein-protein interaction studies should consider the following methodological approach for immunoprecipitation (IP) applications:

• Pilot optimization: Test various lysis buffers (e.g., RIPA, NP-40, Triton X-100) to determine which best preserves protein-protein interactions while allowing antibody binding.

• Cross-linking optimization: If transient interactions are suspected, implement cross-linking protocols using formaldehyde or DSP (dithiobis(succinimidyl propionate)) at varying concentrations and times.

• Antibody coupling: For cleaner results, consider covalently coupling the antibody to protein A/G beads using dimethyl pimelimidate (DMP).

• Sequential elution: Implement differential elution strategies to distinguish specific from non-specific binding partners.

The success of IP experiments depends significantly on maintaining native protein conformation while ensuring antibody accessibility to the epitope. Researchers should systematically optimize conditions based on protein solubility, complex stability, and antibody binding characteristics.

What are the critical parameters for validating SPAC14C4.10c antibody specificity in genetically modified S. pombe strains?

Validating antibody specificity in genetically modified S. pombe strains is critical for ensuring experimental reliability. A comprehensive validation approach includes:

• Knockout/knockdown validation: Generate SPAC14C4.10c deletion or knockdown strains and confirm signal absence in Western blots.

• Overexpression validation: Create strains with controlled SPAC14C4.10c overexpression and verify signal increase proportional to expression level.

• Epitope-tagged validation: Compare antibody detection with epitope tag detection (e.g., FLAG, HA) in strains expressing tagged SPAC14C4.10c.

• Cross-species validation: Test reactivity in closely related species to establish specificity boundaries.

This systematic validation approach ensures that experimental observations genuinely reflect SPAC14C4.10c biology rather than technical artifacts.

How can researchers optimize Western blotting protocols specifically for SPAC14C4.10c antibody?

Optimizing Western blotting protocols for SPAC14C4.10c antibody requires systematic adaptation of standard procedures. The following methodological approach addresses critical parameters:

• Sample preparation: S. pombe cells should be lysed using glass bead disruption in buffer containing protease inhibitors. A comparison of different lysis buffers (RIPA, NP-40, Triton X-100) can identify optimal conditions for SPAC14C4.10c solubilization and epitope preservation.

• Blocking optimization: Test multiple blocking agents (5% milk, 5% BSA, commercial blockers) to determine which provides optimal signal-to-noise ratio. The polyclonal nature of the antibody may require stricter blocking conditions.

• Antibody dilution: Perform a systematic dilution series (1:500, 1:1000, 1:2000, 1:5000) to identify the optimal concentration that maximizes specific signal while minimizing background.

• Incubation conditions: Compare overnight incubation at 4°C with shorter incubations at room temperature to determine optimal binding conditions.

• Detection system selection: For low abundance proteins, enhanced chemiluminescence (ECL) or fluorescent secondary antibodies may provide superior results compared to colorimetric detection.

Researchers should document each optimization step systematically, creating a standardized protocol that ensures reproducibility across experiments and between laboratory members.

What methods can differentiate between specific and non-specific binding when using SPAC14C4.10c antibody?

Distinguishing specific from non-specific binding is critical for accurate data interpretation. Researchers can implement the following methodological approaches:

• Peptide competition assay: Pre-incubate the antibody with increasing concentrations of immunizing peptide before application to samples. Specific signals should decrease proportionally to peptide concentration.

• Gradient loading: Prepare serial dilutions of sample and correlate signal intensity with protein concentration. Specific signals typically show linear correlation with protein amount.

• Differential extraction: Compare antibody performance across different subcellular fractions, as specific binding should correlate with known protein localization.

• Alternative antibody comparison: If available, compare results with another antibody raised against a different epitope of SPAC14C4.10c.

• Mass spectrometry validation: Immunoprecipitate the protein using the antibody and verify identity through mass spectrometry analysis.

By implementing these approaches systematically, researchers can establish confidence thresholds for interpreting signals as specific recognition of SPAC14C4.10c.

How can researchers effectively troubleshoot weak or absent signals when using SPAC14C4.10c antibody?

When encountering weak or absent signals with SPAC14C4.10c antibody, a structured troubleshooting approach includes:

• Protein expression verification: Confirm SPAC14C4.10c expression in the sample using RT-PCR or RNA-seq data, as protein may be expressed at low levels or under specific conditions.

• Sample preparation assessment: Evaluate protein extraction efficiency by testing alternative lysis methods and buffer compositions.

• Antibody functionality test: Verify antibody activity using the positive control provided by the manufacturer .

• Signal enhancement strategies:

  • Increase protein loading (up to 50-100 μg per lane)

  • Extend primary antibody incubation (overnight at 4°C)

  • Implement signal amplification systems (biotin-streptavidin, tyramide)

  • Use more sensitive detection substrates

• Epitope accessibility evaluation: Test different denaturing conditions, as some epitopes may be masked in certain conformations.

Each troubleshooting step should be documented and performed with appropriate controls to identify the specific factor limiting antibody performance in the experimental system.

How can computational approaches enhance SPAC14C4.10c antibody experimental design and interpretation?

Integrating computational approaches with experimental work significantly enhances SPAC14C4.10c antibody research. Researchers can implement the following methodology:

• Structure prediction and epitope mapping: Utilize homology modeling to predict SPAC14C4.10c structure and identify surface-exposed regions as potential epitopes . This informs expectations about antibody accessibility in different experimental conditions.

• Cross-reactivity prediction: Perform BLAST searches and structural alignments to identify proteins with similar epitopes, enabling anticipation of potential cross-reactivity.

• Post-translational modification prediction: Use computational tools to predict potential phosphorylation, glycosylation, or other modifications that might affect antibody binding.

• Experimental design optimization: Simulate experimental conditions computationally to predict optimal parameters before laboratory implementation.

What methodological approaches can reveal SPAC14C4.10c conformational changes using antibody-based techniques?

Detecting conformational changes in SPAC14C4.10c requires specialized antibody-based approaches:

• Conformation-specific antibody development: Generate and characterize antibodies against different conformational states of the protein through strategic immunization protocols.

• Limited proteolysis with antibody protection: Perform protease digestion in the presence and absence of antibody to identify regions protected by antibody binding, which may differ between conformational states.

• Differential scanning fluorimetry with antibody: Monitor protein thermal stability shifts upon antibody binding to detect conformational differences.

• FRET-based approaches: Develop fluorescently labeled antibody pairs that enable Förster resonance energy transfer when bound to specific conformational states.

• Native vs. denaturing comparison: Systematically compare antibody recognition under native and denaturing conditions across experimental conditions suspected to induce conformational changes.

These methodologies provide insights into protein dynamics that extend beyond simple presence/absence detection, revealing functional aspects of SPAC14C4.10c in cellular processes.

How can SPAC14C4.10c antibody be adapted for super-resolution microscopy applications?

Adapting SPAC14C4.10c antibody for super-resolution microscopy requires specialized methodological considerations:

• Antibody fragmentation: Consider using Fab fragments rather than complete IgG to reduce the distance between fluorophore and target, improving localization precision.

• Direct fluorophore conjugation: Directly label purified antibody with appropriate fluorophores (e.g., Alexa Fluor 647 for STORM, ATTO 488 for STED) using commercial conjugation kits optimized for super-resolution applications.

• Fixation optimization: Systematically test fixation methods (paraformaldehyde, methanol, glutaraldehyde) at different concentrations and durations to preserve structure while maintaining epitope accessibility.

• Blocking and permeabilization: Develop optimized protocols that minimize non-specific binding while ensuring antibody penetration.

• Validation through correlative microscopy: Confirm specificity of super-resolution localization through correlation with other imaging modalities or orthogonal techniques.

This methodological adaptation enables visualization of SPAC14C4.10c spatial organization at nanoscale resolution, potentially revealing previously undetectable functional compartmentalization or protein complexes.

What statistical approaches are most appropriate for quantifying SPAC14C4.10c expression using antibody-based assays?

Quantitative analysis of SPAC14C4.10c expression requires rigorous statistical methodology:

• Normalization strategy selection: Compare different normalization approaches (housekeeping proteins, total protein staining) to identify the most stable reference across experimental conditions.

• Dynamic range assessment: Determine the linear quantification range through standard curve analysis using recombinant protein or overexpression systems.

• Statistical test selection: Apply appropriate statistical tests based on data distribution and experimental design:

  • Parametric tests (t-test, ANOVA) for normally distributed data

  • Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis) for non-normal distributions

  • Mixed models for experimental designs with multiple variables

• Sample size determination: Perform power analysis to determine minimum sample size needed for reliable detection of anticipated effect sizes.

• Variance component analysis: Identify and quantify sources of technical and biological variability to improve experimental design.

How should conflicting results between antibody-based detection and genetic expression data for SPAC14C4.10c be reconciled?

When antibody-based protein detection conflicts with genetic expression data, a systematic reconciliation approach includes:

• Temporal consideration: Assess whether discrepancies might result from time delays between transcription and translation, or differences in mRNA versus protein stability.

• Post-transcriptional regulation assessment: Investigate potential microRNA regulation, alternative splicing, or other post-transcriptional mechanisms affecting translation efficiency.

• Protein degradation evaluation: Examine whether proteasomal or autophagic degradation might explain low protein levels despite high mRNA expression.

• Technical validation: Re-evaluate both antibody specificity and genetic expression measurement methodology through alternative techniques.

• Biological context integration: Consider cellular compartmentalization, complex formation, or condition-specific regulation that might affect either detection method.

This reconciliation methodology transforms apparent contradictions into opportunities for discovering novel regulatory mechanisms affecting SPAC14C4.10c expression and function.